Use Options For a Chance To Buy FOLD at a 58% Discount
May 05, 2015 at 11:43 AM EDT
Looking back to 168 days ago, Amicus Therapeutics Inc (FOLD) priced a 13,850,000 share secondary stock offering at $6.50 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Tuesday, the stock is now 57.4% above the offering price..